 Sudipta Panja
Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lens, Crystalline | 4 | 2026 | 83 | 2.520 |
Why?
| | Lysine | 5 | 2026 | 272 | 2.040 |
Why?
| | Glycation End Products, Advanced | 3 | 2026 | 41 | 2.030 |
Why?
| | Nanoparticles | 9 | 2025 | 519 | 1.840 |
Why?
| | Crystallins | 3 | 2025 | 29 | 1.840 |
Why?
| | Presbyopia | 2 | 2023 | 11 | 1.520 |
Why?
| | Polyesters | 4 | 2021 | 78 | 1.270 |
Why?
| | Polymers | 6 | 2025 | 494 | 1.130 |
Why?
| | Receptors, CXCR4 | 2 | 2025 | 91 | 1.080 |
Why?
| | Prodrugs | 2 | 2025 | 52 | 1.020 |
Why?
| | gamma-Crystallins | 1 | 2026 | 2 | 0.960 |
Why?
| | Protein Processing, Post-Translational | 2 | 2026 | 468 | 0.950 |
Why?
| | Proviruses | 1 | 2025 | 16 | 0.910 |
Why?
| | Glyoxal | 1 | 2025 | 12 | 0.880 |
Why?
| | Pyruvaldehyde | 1 | 2025 | 20 | 0.870 |
Why?
| | Lipids | 4 | 2025 | 709 | 0.840 |
Why?
| | Cysteine | 1 | 2025 | 208 | 0.800 |
Why?
| | Deoxycytidine | 1 | 2025 | 222 | 0.800 |
Why?
| | Liposomes | 4 | 2025 | 259 | 0.790 |
Why?
| | DNA, Viral | 1 | 2025 | 357 | 0.770 |
Why?
| | Flavin-Adenine Dinucleotide | 1 | 2022 | 16 | 0.760 |
Why?
| | Sulfhydryl Compounds | 1 | 2024 | 188 | 0.720 |
Why?
| | HIV-1 | 2 | 2025 | 905 | 0.720 |
Why?
| | Elastomers | 1 | 2021 | 30 | 0.690 |
Why?
| | Pancreatic Neoplasms | 3 | 2025 | 928 | 0.690 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2025 | 294 | 0.670 |
Why?
| | Drug Carriers | 4 | 2022 | 134 | 0.670 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 187 | 0.670 |
Why?
| | Amyloid beta-Peptides | 1 | 2022 | 248 | 0.620 |
Why?
| | Drug Delivery Systems | 5 | 2025 | 382 | 0.600 |
Why?
| | Lecithins | 1 | 2019 | 5 | 0.590 |
Why?
| | Caseins | 1 | 2019 | 20 | 0.590 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2019 | 81 | 0.580 |
Why?
| | Macromolecular Substances | 1 | 2019 | 219 | 0.560 |
Why?
| | Antineoplastic Agents | 3 | 2025 | 2207 | 0.560 |
Why?
| | Bacterial Infections | 1 | 2019 | 247 | 0.510 |
Why?
| | Tandem Mass Spectrometry | 3 | 2026 | 566 | 0.490 |
Why?
| | Reperfusion Injury | 3 | 2025 | 297 | 0.480 |
Why?
| | Muramidase | 1 | 2016 | 66 | 0.470 |
Why?
| | Cell Membrane | 1 | 2019 | 707 | 0.460 |
Why?
| | Silanes | 1 | 2013 | 17 | 0.400 |
Why?
| | Solubility | 3 | 2023 | 237 | 0.390 |
Why?
| | Doxorubicin | 1 | 2015 | 398 | 0.390 |
Why?
| | Acetylation | 2 | 2024 | 250 | 0.380 |
Why?
| | Animals | 17 | 2025 | 38141 | 0.380 |
Why?
| | Disulfides | 2 | 2023 | 94 | 0.370 |
Why?
| | Bacteria | 1 | 2019 | 897 | 0.370 |
Why?
| | RNA, Small Interfering | 3 | 2024 | 632 | 0.370 |
Why?
| | Chromatography, Liquid | 2 | 2023 | 445 | 0.330 |
Why?
| | Mice | 10 | 2025 | 18338 | 0.330 |
Why?
| | Acute Kidney Injury | 3 | 2024 | 873 | 0.320 |
Why?
| | Water | 2 | 2023 | 468 | 0.300 |
Why?
| | Humans | 28 | 2026 | 145491 | 0.280 |
Why?
| | Anti-Bacterial Agents | 1 | 2019 | 1953 | 0.280 |
Why?
| | Chloroquine | 2 | 2025 | 54 | 0.270 |
Why?
| | Asparagine | 1 | 2026 | 34 | 0.240 |
Why?
| | Aspartic Acid | 1 | 2026 | 87 | 0.230 |
Why?
| | Protein Deglycase DJ-1 | 1 | 2025 | 13 | 0.230 |
Why?
| | Proteins | 2 | 2026 | 1020 | 0.230 |
Why?
| | Amides | 1 | 2026 | 99 | 0.230 |
Why?
| | Alkylation | 1 | 2025 | 26 | 0.220 |
Why?
| | Rilpivirine | 1 | 2025 | 10 | 0.220 |
Why?
| | Retinal Vessels | 1 | 2025 | 69 | 0.220 |
Why?
| | Dystrophin-Associated Proteins | 1 | 2024 | 6 | 0.220 |
Why?
| | Inulin | 1 | 2024 | 12 | 0.220 |
Why?
| | Silicone Oils | 1 | 2025 | 37 | 0.220 |
Why?
| | Arginine | 1 | 2026 | 238 | 0.220 |
Why?
| | Receptors, CCR5 | 1 | 2025 | 60 | 0.210 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 2 | 2015 | 89 | 0.210 |
Why?
| | Acetyl Coenzyme A | 1 | 2024 | 7 | 0.210 |
Why?
| | Dystrophin | 1 | 2024 | 41 | 0.210 |
Why?
| | Mice, Inbred C57BL | 3 | 2025 | 5989 | 0.210 |
Why?
| | Protein Aggregates | 1 | 2025 | 84 | 0.210 |
Why?
| | Protein Binding | 5 | 2025 | 2250 | 0.210 |
Why?
| | Theranostic Nanomedicine | 1 | 2024 | 15 | 0.200 |
Why?
| | Colitis, Ulcerative | 1 | 2025 | 148 | 0.200 |
Why?
| | Cataract | 1 | 2026 | 212 | 0.200 |
Why?
| | Blood-Brain Barrier | 1 | 2025 | 157 | 0.200 |
Why?
| | Mice, Nude | 1 | 2025 | 678 | 0.190 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2024 | 536 | 0.190 |
Why?
| | Diabetic Retinopathy | 1 | 2025 | 201 | 0.190 |
Why?
| | Protein Isoforms | 1 | 2024 | 396 | 0.190 |
Why?
| | Cell Survival | 3 | 2015 | 1094 | 0.190 |
Why?
| | HeLa Cells | 2 | 2015 | 633 | 0.190 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2022 | 35 | 0.190 |
Why?
| | NADH, NADPH Oxidoreductases | 1 | 2022 | 25 | 0.190 |
Why?
| | Gene Transfer Techniques | 1 | 2024 | 186 | 0.190 |
Why?
| | Reactive Oxygen Species | 1 | 2025 | 602 | 0.180 |
Why?
| | Benzoquinones | 1 | 2022 | 47 | 0.180 |
Why?
| | NAD | 1 | 2022 | 82 | 0.180 |
Why?
| | Neoplasm Metastasis | 1 | 2025 | 691 | 0.180 |
Why?
| | Heterocyclic Compounds | 1 | 2022 | 24 | 0.180 |
Why?
| | Genetic Therapy | 1 | 2024 | 316 | 0.180 |
Why?
| | Chitosan | 1 | 2022 | 39 | 0.180 |
Why?
| | Nucleic Acids | 1 | 2022 | 72 | 0.170 |
Why?
| | Calorimetry | 2 | 2025 | 69 | 0.170 |
Why?
| | Circular Dichroism | 2 | 2025 | 144 | 0.170 |
Why?
| | Spectrometry, Fluorescence | 2 | 2019 | 159 | 0.170 |
Why?
| | Fluorocarbons | 1 | 2022 | 119 | 0.160 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 130 | 0.160 |
Why?
| | Cell Movement | 1 | 2025 | 961 | 0.160 |
Why?
| | Binding Sites | 3 | 2023 | 1313 | 0.150 |
Why?
| | Cell Line, Tumor | 2 | 2025 | 3537 | 0.150 |
Why?
| | Thermodynamics | 3 | 2016 | 427 | 0.150 |
Why?
| | Styrenes | 1 | 2019 | 4 | 0.150 |
Why?
| | Pyrans | 1 | 2019 | 7 | 0.150 |
Why?
| | HIV Infections | 2 | 2025 | 3189 | 0.150 |
Why?
| | Endothelial Cells | 1 | 2025 | 866 | 0.150 |
Why?
| | Spectrophotometry, Ultraviolet | 2 | 2016 | 84 | 0.150 |
Why?
| | Tissue Scaffolds | 1 | 2021 | 223 | 0.150 |
Why?
| | Endothelium, Vascular | 1 | 2025 | 951 | 0.140 |
Why?
| | Micelles | 2 | 2015 | 40 | 0.140 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2025 | 994 | 0.140 |
Why?
| | Molecular Docking Simulation | 2 | 2016 | 123 | 0.140 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2025 | 1138 | 0.140 |
Why?
| | Antibodies, Neutralizing | 1 | 2021 | 342 | 0.140 |
Why?
| | Antibodies, Monoclonal | 1 | 2025 | 1511 | 0.130 |
Why?
| | Particle Size | 1 | 2019 | 402 | 0.130 |
Why?
| | Biocompatible Materials | 1 | 2021 | 436 | 0.130 |
Why?
| | Cell Proliferation | 1 | 2025 | 2499 | 0.130 |
Why?
| | Protein Domains | 3 | 2024 | 314 | 0.130 |
Why?
| | Tissue Engineering | 1 | 2021 | 441 | 0.130 |
Why?
| | Tartrazine | 1 | 2016 | 1 | 0.120 |
Why?
| | Static Electricity | 1 | 2016 | 114 | 0.120 |
Why?
| | Thermogravimetry | 1 | 2015 | 6 | 0.120 |
Why?
| | Chickens | 1 | 2016 | 184 | 0.120 |
Why?
| | Magnetic Fields | 1 | 2015 | 24 | 0.120 |
Why?
| | Magnetics | 1 | 2015 | 47 | 0.110 |
Why?
| | Urethane | 1 | 2015 | 43 | 0.110 |
Why?
| | Stilbenes | 1 | 2015 | 33 | 0.110 |
Why?
| | X-Ray Diffraction | 1 | 2015 | 84 | 0.110 |
Why?
| | Aging | 1 | 2026 | 1940 | 0.110 |
Why?
| | Protein Structure, Secondary | 1 | 2016 | 366 | 0.110 |
Why?
| | Endocytosis | 1 | 2015 | 168 | 0.110 |
Why?
| | Serum Albumin, Bovine | 1 | 2014 | 59 | 0.110 |
Why?
| | Surface Properties | 1 | 2015 | 398 | 0.100 |
Why?
| | Microscopy, Fluorescence | 1 | 2015 | 407 | 0.100 |
Why?
| | Propylamines | 1 | 2013 | 11 | 0.100 |
Why?
| | Blood Proteins | 1 | 2015 | 230 | 0.100 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 141 | 0.100 |
Why?
| | Protein Stability | 2 | 2025 | 178 | 0.090 |
Why?
| | Aged | 2 | 2023 | 26125 | 0.090 |
Why?
| | Molecular Structure | 1 | 2013 | 498 | 0.090 |
Why?
| | Polyamines | 2 | 2022 | 41 | 0.090 |
Why?
| | Administration, Oral | 2 | 2025 | 863 | 0.090 |
Why?
| | Mutation | 1 | 2022 | 4093 | 0.090 |
Why?
| | Kidney | 3 | 2024 | 1498 | 0.080 |
Why?
| | Neoplasms | 2 | 2024 | 2897 | 0.080 |
Why?
| | Polyethylene Glycols | 1 | 2015 | 652 | 0.080 |
Why?
| | Ligands | 2 | 2025 | 667 | 0.070 |
Why?
| | Lung Neoplasms | 1 | 2022 | 2664 | 0.070 |
Why?
| | Directed Molecular Evolution | 1 | 2026 | 30 | 0.060 |
Why?
| | Protein Structure, Tertiary | 2 | 2021 | 850 | 0.060 |
Why?
| | Glycosylation | 1 | 2026 | 161 | 0.060 |
Why?
| | Protein Engineering | 1 | 2026 | 123 | 0.060 |
Why?
| | Emulsions | 1 | 2025 | 59 | 0.060 |
Why?
| | Adsorption | 1 | 2025 | 153 | 0.050 |
Why?
| | Drug Stability | 1 | 2025 | 169 | 0.050 |
Why?
| | Capillaries | 1 | 2025 | 120 | 0.050 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2024 | 93 | 0.050 |
Why?
| | Receptors, Virus | 1 | 2023 | 96 | 0.050 |
Why?
| | Blotting, Western | 1 | 2025 | 1162 | 0.050 |
Why?
| | Oxidation-Reduction | 1 | 2026 | 1080 | 0.050 |
Why?
| | Polyelectrolytes | 1 | 2022 | 15 | 0.050 |
Why?
| | Spermine | 1 | 2022 | 29 | 0.050 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 2022 | 28 | 0.050 |
Why?
| | Male | 4 | 2025 | 72817 | 0.040 |
Why?
| | Hydroxychloroquine | 1 | 2022 | 65 | 0.040 |
Why?
| | NF-kappa B | 1 | 2025 | 660 | 0.040 |
Why?
| | Antigen-Antibody Reactions | 1 | 2021 | 50 | 0.040 |
Why?
| | Transition Temperature | 1 | 2021 | 28 | 0.040 |
Why?
| | Virus Replication | 1 | 2025 | 527 | 0.040 |
Why?
| | Tissue Distribution | 1 | 2022 | 335 | 0.040 |
Why?
| | Mammals | 1 | 2022 | 296 | 0.040 |
Why?
| | Gastrointestinal Tract | 1 | 2022 | 208 | 0.040 |
Why?
| | Hyaluronic Acid | 1 | 2022 | 225 | 0.040 |
Why?
| | Precision Medicine | 1 | 2024 | 456 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 743 | 0.040 |
Why?
| | Recombinant Proteins | 1 | 2021 | 1367 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2025 | 4127 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2022 | 737 | 0.030 |
Why?
| | Apoptosis | 1 | 2025 | 2411 | 0.030 |
Why?
| | Anti-HIV Agents | 1 | 2025 | 908 | 0.030 |
Why?
| | Macrophages | 1 | 2025 | 1509 | 0.030 |
Why?
| | Adult | 1 | 2019 | 40707 | 0.030 |
Why?
| | Hydrogen Bonding | 1 | 2015 | 169 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2025 | 4559 | 0.030 |
Why?
| | Female | 2 | 2022 | 78763 | 0.030 |
Why?
| | Drug Compounding | 1 | 2015 | 107 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 2146 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2014 | 563 | 0.020 |
Why?
| | Temperature | 1 | 2015 | 681 | 0.020 |
Why?
| | Cattle | 1 | 2014 | 977 | 0.020 |
Why?
| | Protein Conformation | 1 | 2014 | 935 | 0.020 |
Why?
| | Cell Line | 1 | 2015 | 2823 | 0.020 |
Why?
| | Insulin | 1 | 2015 | 2506 | 0.010 |
Why?
|
|
Panja's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|